BioVie Shares jump Premarket on Parkinson’s, Alzheimer’s Studies >BIVI
admin By Colin Kellaher Shares of BioVie Inc. rose sharply in premarket trading Tuesday after the…
Read MoreMental Disorders
Roche says Phase 3 studies for Alzheimer’s drug failed to meet primary endpoints
Roche Holding AG said Monday that Phase 3 Graduate studies of gantenerumab, for treatment of…
Read MoreTry these simple rules for making food choices that could reduce your risk of dementia
A study published in July 2022 in Neurology, a journal from the American Academy of…
Read MoreWana Brands CEO makes seven-figure donation to fund cannabis research
Wana Brands founder and CEO Nancy Whiteman is stepping up her charitable activities with $3…
Read MoreWhat neuroscientists have learned about rejuvenating the aging brain—and what you can do too
We all understand that no magic elixir can stop or even slow the human brain…
Read MoreWhen will we care as much about Alzheimer’s as we did about COVID-19?
Where is the hysteria? Where is the mass panic? Where is the preening virtue signaling?…
Read More4 things you can do to fight dementia and improve your memory
There may not be a “magic pill,” but there are ways to stave off dementia…
Read MoreBiogen and Eisai make plans to take another Alzheimer’s drug to the FDA
Biogen Inc. BIIB, -1.93% and Eisai Co. Ltd. 4523, +3.57% are getting closer to a…
Read MorePeople who do this one thing have HALF the Alzheimer’s risk
The things to remember about dementia are that it is absolutely horrible for you and…
Read More
Want to slow, delay or reverse dementia? Try this classic game.
A couple of years ago I bought a big book of crosswords and started doing…
Read More